.jpg)
Chief, Division of Vascular Neurology
University of Utah
JENNIFER JUHL MAJERSIK,
MD, MS
Chief, Division of Vascular Neurology
Dr. Majersik is a Professor of Neurology at the University of Utah, School of Medicine. After
receiving her B.S. in Physics from Harvey Mudd College (Claremont, CA), she served in the Air
Force as a Scientific Analyst at Wright-Patterson Air Force Base National Air Intelligence Center. In
1997, she attended medical school at University of Vermont (Burlington, VT) where she fell in love
with the neurosciences. She completed internship and neurology residency at the University of
Utah and then decided to seek additional expertise in stroke by completing a vascular neurology
fellowship at University of Michigan (Ann Arbor, MI). While at Michigan, she earned a master's
degree in clinical research design and biostatistics through their School of Public Health.
In 2008, Dr. Majersik returned to Salt Lake City to establish her vascular neurology practice within
the Stroke Center at the University of Utah. Her clinical practice includes evaluating and treating
acute strokes in the hospital and emergency department, managing patients on the inpatient
general neurology service, and providing outpatient consultation in the stroke clinic, including
(https://mychart.med.utah.edu/mychart/)
JENNIFER JUHL MAJERSIK,
MD, MS
Chief, Division of Vascular Neurology
Clinical Information Academic Information Clinical Trials Videos & News
(//HEALTHCARE.UTAH.EDU/INDEX.PHP) MENU
ge e a eu o ogy se ce, a d p o d g ou pa e co su a o e s o e c c, c ud g
urgent referrals. She has a particular interest in rare single gene disorders causing stroke (such as
CADASIL), hypercoaguable states (such as Antiphospholipid Antibody Syndrome), and vascular
malformations (such as cavernous malformations and hereditary hemorrhagic telangiectasias).
She also provides emergency consultation to stroke patients at community hospitals via the
telestroke network.
In 2010, she became Director of the University of Utah Stroke Center. Dr. Majersik is currently
studying the genetic underpinnings of stroke in large families in Utah and more common
polygenetic disorders leading to increased risk of stroke as well as conducting a study on motor
recovery after stroke.
She lives here in Salt Lake City and enjoys hiking the mountains and raising her family.
801-587-9935
175 North Medical Drive East
University of Utah Neurology, 3135
Salt Lake City,
UT
84132
Academic
Departments
Neurology
-
Professor
Academic Divisions Vascular Neurology
Board Certification American Board of Psychiatry & Neurology (Neurology)
American Board of Psychiatry & Neurology (Sub: Vascular
Neurology)
Academic Locations
Clinical Neurosciences Center
BOARD CERTIFICATION AND ACADEMIC INFORMATION
Graduate Training University of Michigan
Clinical Research/Stat Aly
M.S.
Fellowship University of Michigan
Vascular Neurology
Fellow
Residency University of Utah School of Medicine
Neurology
Resident
Internship University of Utah School of Medicine
Internal Medicine
Intern
Professional Medical University of Vermont College of Medicine
Medicine
M.D.
Undergraduate Harvey Mudd College
Physics
B.S.
Human Population Genetics
Neurogenetics
Costs and Cost Analysis
Antiphospholipid Syndrome
Genetic Epidemiology
Epidemiology
International Health
Stroke
Telehealth
RESEARCH INTERESTS
EDUCATION HISTORY
SELECTED PUBLICATIONS - JOURNAL ARTICLES
1. Majersik JJ, Ahmed A, Chen IA, Shill H, Hanes GP, Pelak VS, Hopp JL, Omuro A, Kluger B, Leslie-
Mazwi T (2021). A Shortage of Neurologists We Must Act Now: A Report From the AAN 2019
Transforming Leaders Program. (Epub ahead of print) Neurology.
(http://www.ncbi.nlm.nih.gov/pubmed/33931527)
2. Ravindra VM, Grandhi R, Delic A, Hohmann S, Shippey E, Tirschwell D, Frontera JA, Yaghi S, Majersik
JJ, Anadani M, de Havenon A (2021). Impact of COVID-19 on the hospitalization, treatment, and
outcomes of intracerebral and subarachnoid hemorrhage in the United States. PLoS ONE, 16(4),
e0248728. (http://www.ncbi.nlm.nih.gov/pubmed/33852591)
3. Kashida YT, Garcia-Esperon C, Lillicrap T, Miteff F, Garcia-Bermejo P, Gangadharan S, Chew BLA,
OBrien W, Evans J, Alanati K, Bivard A, Parsons M, Majersik JJ, Spratt NJ, Levi C, members of
Northern NSW Telestroke investigators for this project (2021). The Need for Structured Strategies to
Improve Stroke Care in a Rural Telestroke Network in Northern New South Wales, Australia: An
Observational Study. Front Neurol, 12, 645088. (http://www.ncbi.nlm.nih.gov/pubmed/33897601)
4. Lindgren A, Braun R, Majersik JJ, Clatworthy P, Mainali S, Derdeyn CP, Maguire JM, Jern C, Rosand J,
Cole JW, Lee JM, Khatri P, Nyquist PA, Debette SP, Keat Wei L, Rundek T, Leifer D, Thijs V, Lemmens R,
Heitsch L, Prasad K, Jimenez-Conde J, Dichgans M, Rost NS, Cramer SC, Bernhardt J, Worrall BB,
Cadenas I (2021). EXPRESS: International Stroke Genetics Consortium Recommendations for Studies
of Genetics of Stroke Outcome and Recovery. Int J Stroke, 17474930211007288.
(http://www.ncbi.nlm.nih.gov/pubmed/33739214)
5. Bailey RR, Singleton JR, Majersik JJ (2020). Association of obesity and diabetes with physical activity
and fruit and vegetable consumption in stroke survivors. Fam Pract, 38(1), 56-61.
(http://www.ncbi.nlm.nih.gov/pubmed/32968806)
6. Poon JT, Tkach A, Havenon AH, Hoversten K, Johnson J, Hannon PM, Chung LS, Majersik JJ (2021).
Telestroke consultation can accurately diagnose ischemic stroke mimics. J Telemed Telecare,
1357633X21989558. (http://www.ncbi.nlm.nih.gov/pubmed/33535915)
7. de Havenon A, Ney JP, Callaghan B, Delic A, Hohmann S, Shippey E, Esper GJ, Stulberg E, Tirschwell
D, Frontera J, Yaghi S, Anadani M, Majersik JJ (2020). Impact of COVID-19 on Outcomes in Ischemic
Stroke Patients in the United States. Journal of Stroke and Cerebrovascular Diseases, 30(2), 105535.
(http://www.ncbi.nlm.nih.gov/pubmed/33310595)
8. Tekiela P, Majersik JJ (2021). The Impact of COVID-19 on Developing Neurologic Disorders.
Neurology, 96(4), e647-e649. (http://www.ncbi.nlm.nih.gov/pubmed/33495396)
9. Majersik JJ (2021). Reader Response: Neuro R2 Score: Predicting High-Risk Neurologic Readmissions
Within 30 Days. Neurology, 96(2), 84. (http://www.ncbi.nlm.nih.gov/pubmed/33431625)
0. Baradaran H, Delic A, Wong KH, Sheibani N, Alexander M, McNally JS, Majersik JJ, De Havenon A
(2021). Using Ultrasound and Inflammation to Improve Prediction of Ischemic Stroke: A Secondary
Analysis of the Multi-Ethnic Study of Atherosclerosis. Cerebrovasc Dis Extra, 11(1), 37-43.
(h // bi l ih / b d/ )
Journal Article
(http://www.ncbi.nlm.nih.gov/pubmed/33601394)
1. Wong KH, Hu K, Peterson C, Sheibani N, Tsivgoulis G, Majersik JJ, de Havenon AH (2020). Diabetic
Retinopathy and Risk of Stroke: A Secondary Analysis of the ACCORD Eye Study. Stroke, 51(12), 3733-
3736. (http://www.ncbi.nlm.nih.gov/pubmed/33019896)
2. Goldstein ED, Shakoor A, Majersik JJ (2020). Branch Retinal Vein Occlusion and Venous
Abnormalities in CADASIL. Neurologist, 25(6), 178-179.
(http://www.ncbi.nlm.nih.gov/pubmed/33181727)
3. Zha AM, Chung LS, Song SS, Majersik JJ, Jagolino-Cole AL (2020). Training in Neurology: Adoption of
resident teleneurology training in the wake of COVID-19: Telemedicine crash course. Neurology,
95(9), 404-407. (http://www.ncbi.nlm.nih.gov/pubmed/32554768)
4. Leira EC, Russman AN, Biller J, Brown DL, Bushnell CD, Caso V, Chamorro A, Creutzfeldt CJ, Cruz-
Flores S, Elkind MSV, Fayad P, Froehler MT, Goldstein LB, Gonzales NR, Kaskie B, Khatri P, Livesay S,
Liebeskind DS, Majersik JJ, Moheet AM, Romano JG, Sanossian N, Sansing LH, Silver B, Simpkins AN,
Smith W, Tirschwell DL, Wang DZ, Yavagal DR, Worrall BB (2020). Preserving stroke care during the
COVID-19 pandemic: Potential issues and solutions. Neurology, 95(3), 124-133.
(http://www.ncbi.nlm.nih.gov/pubmed/32385186)
5. Goldstein ED, Majersik JJ, McNally S (2020). Intracranial high-resolution vessel wall imaging in
CADASIL. Neurology, 94(23), 1040-1041. (http://www.ncbi.nlm.nih.gov/pubmed/32430314)
6. Traenka C, Grond-Ginsbach C, Goeggel Simonetti B, Metso TM, Debette S, Pezzini A, Kloss M,
Majersik JJ, Southerland AM, Leys D, Baumgartner R, Caso V, Bjot Y, De Marchis GM, Fischer U,
Polymeris A, Sarikaya H, Thijs V, Worrall BB, Bersano A, Brandt T, Gensicke H, Bonati LH, Touze E,
Martin JJ, Chabriat H, Tatlisumak T, Arnold M, Engelter ST, Lyrer P, CADISP-Plus Study Group (2019).
Artery occlusion independently predicts unfavorable outcome in cervical artery dissection.
Neurology, 94(2), e170-e180. (http://www.ncbi.nlm.nih.gov/pubmed/31757869)
7. de Havenon A, Chung LS, Smith J, Taylor K, Majersik JJ, Chauhan N (2019). Less Experienced
Telestroke Consultants Are More Likely to Go On-Camera, but Less Likely to Give tPA. Stroke Res
Treat, 2019, 1059369. (http://www.ncbi.nlm.nih.gov/pubmed/31814959)
8. de Havenon A, Fino NF, Johnson B, Wong KH, Majersik JJ, Tirschwell D, Rost N (2019). Blood Pressure
Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of
PRoFESS. Stroke, 50(11), 3170-3176. (http://www.ncbi.nlm.nih.gov/pubmed/31537194)
9. de Havenon A, Wong KH, Elkhetali A, McNally JS, Majersik JJ, Rost NS (2019). Carotid Artery Stiffness
Accurately Predicts White Matter Hyperintensity Volume 20 Years Later: A Secondary Analysis of the
Atherosclerosis Risk in the Community Study. AJNR Am J Neuroradiol, 40(8), 1369-1373.
(http://www.ncbi.nlm.nih.gov/pubmed/31248859)
0. Majersik JJ (2019). Ethics and Bias in Clinical Trial Enrollment in Stroke. Curr Cardiol Rep, 21(6), 49.
(http://www.ncbi.nlm.nih.gov/pubmed/31011843)
1. Touz E, Southerland AM, Boulanger M, Labeyrie PE, Azizi M, Bouatia-Naji N, Debette S, Gornik HL,
Hussain SM, Jeunemaitre X, Joux J, Kirton A, Le Hello C, Majersik JJ, Mocco J, Persu A, Sharma A,
Worrall BB, Olin JW, Plouin PF (2018). Fibromuscular Dysplasia and Its Neurologic Manifestations: A
S i R i JAMA N l ( ) (h // bi l ih / b d/ )
Systematic Review. JAMA Neurol, 76(2), 217-226. (http://www.ncbi.nlm.nih.gov/pubmed/30285053)
2. de Havenon A, Tirschwell D, Majersik JJ, McNally S, Stoddard G, Moore A, Mossa-Basha M (2017).
Carotid intraplaque hemorrhage on vessel wall MRI does not correlate with TCD emboli monitoring
in patients with recently symptomatic carotid atherosclerosis. Neuroradiol J, 30(5), 486-489.
(http://www.ncbi.nlm.nih.gov/pubmed/28631982)
3. McNally JS, Burton TM, Aldred BW, Kim SE, McLaughlin MS, Eisenmenger LB, Stoddard GJ, Majersik
JJ, Miller DV, Treiman GS, Parker DL (2016). Vitamin D and Vulnerable Carotid Plaque. AJNR Am J
Neuroradiol, 37(11), 2092-2099. (http://www.ncbi.nlm.nih.gov/pubmed/27313129)
4. Nelson RE, Okon N, Lesko AC, Majersik JJ, Bhatt A, Baraban E (2015). The cost-effectiveness of
telestroke in the Pacific Northwest region of the USA. J Telemed Telecare, 22(7), 413-21.
(http://www.ncbi.nlm.nih.gov/pubmed/26541170)
5. Sangle N, Baringer JR, Majersik J, DeWitt LD (2015). CADASIL with Multiorgan Involvement: a
Complete Autopsy Examination Report. Can J Neurol Sci, 43(1), 202-5.
(http://www.ncbi.nlm.nih.gov/pubmed/26138243)
6. de Havenon A, Moore A, Sultan-Qurraie A, Majersik JJ, Stoddard G, Tirschwell D (10/06/2015).
Ischemic stroke patients with active malignancy or extracardiac shunts are more likely to have a
right-to-left shunt found by TCD than echocardiogram. Transl Stroke Res, 6(5), 361-4.
7. de Havenon A, Moore A, Sultan-Qurraie A, Majersik JJ, Stoddard G, Tirschwell D (2015). Ischemic
stroke patients with active malignancy or extracardiac shunts are more likely to have a right-to-left
shunt found by TCD than echocardiogram. Transl Stroke Res, 6(5), 361-4.
(http://www.ncbi.nlm.nih.gov/pubmed/26205844)
8. Sardar P, Chatterjee S, Giri J, Kundu A, Tandar A, Sen P, Nairooz R, Huston J, Ryan JJ, Bashir R, Parikh
SA, White CJ, Meyers PM, Mukherjee D, Majersik JJ, Gray WA (2015). Endovascular therapy for acute
ischaemic stroke: a systematic review and meta-analysis of randomized trials. Eur Heart J, 36(35),
2373-80. (http://www.ncbi.nlm.nih.gov/pubmed/26071599)
9. Debette S, Compter A, Labeyrie MA, Uyttenboogaart M, Metso TM, Majersik JJ, Goeggel-Simonetti
B, Engelter ST, Pezzini A, Bijlenga P, Southerland AM, Naggara O, Bjot Y, Cole JW, Ducros A,
Giacalone G, Schilling S, Reiner P, Sarikaya H, Welleweerd JC, Kappelle LJ, de Borst GJ, Bonati LH,
Jung S, Thijs V, Martin JJ, Brandt T, Grond-Ginsbach C, Kloss M, Mizutani T, Minematsu K, Meschia JF,
Pereira VM, Bersano A, Touz E, Lyrer PA, Leys D, Chabriat H, Markus HS, Worrall BB, Chabrier S,
Baumgartner R, Stapf C, Tatlisumak T, Arnold M, Bousser MG (2015). Epidemiology,
pathophysiology, diagnosis, and management of intracranial artery dissection. Lancet Neurol, 14(6),
640-54. (http://www.ncbi.nlm.nih.gov/pubmed/25987283)
0. Majersik JJ (2014). Comment: Nickel-associated delayed cerebral hypersensitivity- Recognition is
key. Neurology, 84(1), 97. (http://www.ncbi.nlm.nih.gov/pubmed/25428691)
1. Walker KA, Sampson JB, Skalabrin EJ, Majersik JJ (2013). Clinical characteristics and thrombolytic
outcomes of infective endocarditis-associated stroke. Neurohospitalist, 2(3), 87-91.
(http://www.ncbi.nlm.nih.gov/pubmed/23983869)
2. Nelson RE, Saltzman GM, Skalabrin EJ, Demaerschalk BM, Majersik JJ (2011). The cost-effectiveness
f l k i h f i h i k N l ( )
of telestroke in the treatment of acute ischemic stroke. Neurology, 77(17), 1590-8.
(http://www.ncbi.nlm.nih.gov/pubmed/21917781)
3. Cantu-Brito C, Majersik JJ, Snchez BN, Ruano A, Becerra-Mendoza D, Wing JJ, Morgenstern LB
(2011). Door-to-door capture of incident and prevalent stroke cases in Durango, Mexico: the Brain
Attack Surveillance in Durango Study. Stroke, 42(3), 601-6.
(http://www.ncbi.nlm.nih.gov/pubmed/21212398)
4. Arsava EM, Ballabio E, Benner T, Cole JW, Delgado-Martinez MP, Dichgans M, Fazekas F, Furie KL,
Illoh K, Jood K, Kittner S, Lindgren AG, Majersik JJ, Macleod MJ, Meurer WJ, Montaner J, Olugbodi AA,
Pasdar A, Redfors P, Schmidt R, Sharma P, Singhal AB, Sorensen AG, Sudlow C, Thijs V, Worrall BB,
Rosand J, Ay H, International Stroke Genetics Consortium (2010). The Causative Classification of
Stroke system: an international reliability and optimization study. Neurology, 75(14), 1277-84.
(http://www.ncbi.nlm.nih.gov/pubmed/20921513)
5. Arsava EM, Ballabio E, Benner T, Cole JW, Delgado-Martinez MP, Dichgans M, Fazekas F, Furie KL,
Illoh KL, Jood K, Kittner S, Lindgren AG, Majersik JJ, Macleod MJ, Meurer WJ, Montaner JJ, Olugbodi
AA, Pasdar A, Redfors P, Schmidt R, Sharma P, Singhal AB, Sorensen AG, Sudlow C, Thijs V, Worrall
BB, Rosand J, Ay H and On behalf of the International Stroke Genetics Consortium (2010). The
Causative Classification of Stroke System: An International Reliability and Optimization Study.
Neurology, 75, 1277–1284.
6. Meurer WJ, Scott PA, Caveney AF, Majersik JJ, Frederiksen SM, Sandretto A, Holden AB, Silbergleit R
(2010). Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke
patients treated with tissue plasminogen activator. Int J Stroke, 5(3), 163-6.
(http://www.ncbi.nlm.nih.gov/pubmed/20536612)
7. Cantu-Brito C, Majersik JJ, Snchez BN, Ruano A, Quiones G, Arzola J, Morgenstern LB (2010).
Hospitalized stroke surveillance in the community of Durango, Mexico: the brain attack surveillance
in Durango study. Stroke, 41(5), 878-84. (http://www.ncbi.nlm.nih.gov/pubmed/20360543)
8. Cantu-Brito C, Majersik JJ, Snchez BN, Ruano A, Quiones G, ArzolaJ, Morgenstern LB (05/01/2010).
Hospitalized Stroke Surveillance in the Community of Durango, Mexico – the Brain Attack
Surveillance in Durango (BASID) Study. Stroke, 41(5), 878-884.
9. Mullen Conley K, Juhl Majersik J, Gonzales NR, Maddox KE, Pary JK, Brown DL, Moye LA, Espinosa N,
Grotta JC, Morgenstern LB (2010). Kids Identifying and Defeating Stroke (KIDS): development and
implementation of a multiethnic health education intervention to increase stroke awareness among
middle school students and their parents. Health Promotion Practice, 11(1), 95-103.
(http://www.ncbi.nlm.nih.gov/pubmed/18332150)
0. Lisabeth LD, Brown DL, Hughes R, Majersik JJ, Morgenstern LB (2009). Acute stroke symptoms:
comparing women and men. Stroke, 40(6), 2031-6.
(http://www.ncbi.nlm.nih.gov/pubmed/19228858)
1. Brown DL, Zahuranec DB, Majersik JJ, Wren PA, Gruis KL, Zupancic M, Lisabeth LD (2009). Risk of
sleep apnea in orchestra members. Sleep Med, 10(6), 657-60.
(h // bi l ih / b d/ )
(http://www.ncbi.nlm.nih.gov/pubmed/19014898)
2. Lisabeth LD, Brown DL, Hughes R, Majersik JJ, Morgenstern LB (2009). Acute stroke symptoms:
comparing women and men. Stroke, 40(6), 2031-6.
3. Meurer WJ, Snchez BN, Smith MA, Lisabeth LD, Majersik JJ, Brown DL, Uchino K, Bonikowski FP,
Mendizabal JE, Zahuranec DB, Morgenstern LB (2008). Predicting ischaemic stroke subtype from
presenting systolic blood pressure: the BASIC Project. J Intern Med, 265(3), 388-96.
(http://www.ncbi.nlm.nih.gov/pubmed/19019190)
4. Meurer WJ, Sanchez BN, Smith MA, Lisabeth LD, Majersik JJ, Brown DL, Uchino K, Bonikowski FP,
Mendizabal JE, Zahuranec DB, Morgenstern LB (2009). Predicting ischaemic stroke subtype from
presenting systolic blood pressure: the BASIC Project. J Intern Med, 265(3), 388-96.
5. Lisabeth LD, Escobar JD, Dvonch JT, Snchez BN, Majersik JJ, Brown DL, Smith MA, Morgenstern LB
(2008). Ambient air pollution and risk for ischemic stroke and transient ischemic attack. Ann Neurol,
64(1), 53-9. (http://www.ncbi.nlm.nih.gov/pubmed/18508356)
6. Majersik JJ, Silbergleit R, Meurer WJ, Brown DL, Lisabeth LD, Morgenstern LB (2008). Public health
impact of full implementation of therapeutic hypothermia after cardiac arrest. Resuscitation, 77(2),
189-94. (http://www.ncbi.nlm.nih.gov/pubmed/18249484)
7. Brown DL, Morgenstern LB, Majersik JJ, Kleerekoper M, Lisabeth LD (2008). Risk of fractures after
stroke. Cerebrovasc Dis, 25(1-2), 95-9. (http://www.ncbi.nlm.nih.gov/pubmed/18057878)
8. Lisabeth LD, Peyser PA, Long JC, Majersik JJ, Smith MA, Morgenstern LB (2008). Stroke Among
Siblings in a Bi-ethnic Community. Neuroepidemiology, 31, 33-38.
9. Majersik JJ, Smith MA, Zahuranec DB, Snchez BN, Morgenstern LB (2007). Population-based
analysis of the impact of expanding the time window for acute stroke treatment. Stroke, 38(12),
3213-7. (http://www.ncbi.nlm.nih.gov/pubmed/17962593)
0. Majersik JJ, Smith MA, Zahuranec DB, Sanchez BN, Morgenstern LB (2007). Population-based
analysis of the impact of expanding the time window for acute stroke treatment. Stroke, 38(12), 3213-
7.
1. Meurer WJ, Frederiksen SM, Majersik JJ, Zhang L, Sandretto A, Scott PA (2007). Qualitative data
collection and analysis methods: the INSTINCT trial. Acad Emerg Med, 14(11), 1064-71.
(http://www.ncbi.nlm.nih.gov/pubmed/17652268)
2. Majersik JJ, Caravati EM, Steffens JD (2007). Severe neurotoxicity associated with exposure to the
solvent 1-bromopropane (n-propyl bromide). Clin Toxicol (Phila), 45(3), 270-6.
(http://www.ncbi.nlm.nih.gov/pubmed/17453879)
3. Pribble JM, Goldstein KM, Majersik JJ, Barsan WG, Brown DL, Morgenstern LB (2006). Stroke
information reported on local television news: a national perspective. Stroke, 37(6), 1556-7.
(http://www.ncbi.nlm.nih.gov/pubmed/16675736)
4. Pribble JM, Goldstein KM, Majersik JJ, Barsan WG, Brown DL, Morgenstern LB (2006). Stroke
information reported on local television news: a national perspective. Stroke, 37(6), 1556-7.
5. Majersik JJ, Skalabrin EJ (2006). Single-gene stroke disorders. Semin Neurol, 26(1), 33-48.
(http://www.ncbi.nlm.nih.gov/pubmed/16479442)
1. Southerland A, Majersik JJ, Worrall BB (04/29/2015). Chapter 15: Cervical Artery Dissection. In Gilbert
R. Upchurch Jr., Peter K. Henke (Eds.), Clinical Scenarios in Vascular Surgery, Second Edition. LWW.
1. Muir KW, Majersik JJ (2021). Connecting Upper Limb Functional Stroke Recovery to Global Disability
Measures: Finding the Forest in the Trees. Neurology, 96(14), 643-644.
(http://www.ncbi.nlm.nih.gov/pubmed/33589536)
2. Majersik JJ, Reddy VK (2020). Acute neurology during the COVID-19 pandemic: Supporting the front
line. Neurology, 94(24), 1055-1057. (http://www.ncbi.nlm.nih.gov/pubmed/32284363)
3. Majersik JJ, Woo D (2020). The enormous financial impact of stroke disability. Neurology, 94(9), 377-
378. (http://www.ncbi.nlm.nih.gov/pubmed/32029548)
4. Fletcher JJ, Majersik JJ (2016). Stroke systems of care: The sum is greater than the parts. Neurology,
86(10), 886-7. (http://www.ncbi.nlm.nih.gov/pubmed/26850980)
5. Majersik JJ (2015). Doctor, did stress cause my stroke? Neurology, 85(19), 1640-1.
(http://www.ncbi.nlm.nih.gov/pubmed/26468406)
6. Majersik JJ (10/14/2015). Doctor: Did Stress Cause My Stroke? Neurology, 85, 1-2.
7. Majersik JJ, Schmidt RH (2015). Continued risk of SAH after negative screen in first-degree relatives-
-and persistent questions. Neurology, 84(9), 868-9.
(http://www.ncbi.nlm.nih.gov/pubmed/25636712)
8. Majersik JJ, Schmidt RH (03/03/2015). Continued risk of SAH after negative screen in first degree
relatives - and persistent questions. Invited editorial on Rasing I, et al. Longterm risk of
subarachnoid hemorrhage after a negative aneurysm screen. Neurology, 84(9), 868-9.
9. Majersik JJ, Cole JW, Golledge J, Rost NS, Chan YF, Gurol ME, Lindgren AG, Woo D, Fernandez-
Cadenas I, Chen DT, Thijs V, Worrall BB, Kamal A, Bentley P, Wardlaw JM, Ruigrok YM, Battey TW,
Schmidt R, Montaner J, Giese AK, Roquer J, Jimnez-Conde J, Lee C, Ay H, Martin JJ, Rosand J, Maguire
J, International Stroke Genetics Consortium (2014). Recommendations from the international stroke
genetics consortium, part 1: standardized phenotypic data collection. Stroke, 46(1), 279-84.
(http://www.ncbi.nlm.nih.gov/pubmed/25492903)
0. Battey TW, Valant V, Kassis SB, Kourkoulis C, Lee C, Anderson CD, Falcone GJ, Jimenez-Conde J,
Fernandez-Cadenas I, Pare G, Rundek T, James ML, Lemmens R, Lee TH, Tatlisumak T, Kittner SJ,
Lindgren A, Mateen FJ, Berkowitz AL, Holliday EG, Majersik J, Maguire J, Sudlow C, Rosand J,
International Stroke Genetics Consortium (2014). Recommendations from the international stroke
genetics consortium, part 2: biological sample collection and storage. Stroke, 46(1), 285-90.
(http://www.ncbi.nlm.nih.gov/pubmed/25492904)
Book Chapter
Editorial
1. de Havenon A, Yaghi S, Majersik JJ, Hohmann S, Ney JP, Callaghan B, Anadani M (2021). Acute
Coronary Syndrome and Ischemic Stroke Discharges in the United States During the COVID-19
Pandemic. [Letter to the editor]. Stroke, STROKEAHA120033630.
(http://www.ncbi.nlm.nih.gov/pubmed/33874741)
2. de Havenon A, Ney JP, Callaghan B, Yaghi S, Majersik JJ (2020). Excess neurological death in New
York City after the emergence of COVID-19. [Letter to the editor]. J Neurol.
(http://www.ncbi.nlm.nih.gov/pubmed/32691234)
1. McNally JS, Aldred B, Burton T, McLauglin M, Kim S, Miller D, Majersik J, Parker D, Treiman G (2015).
Vitamin D and Vulnerable Carotid Plaque. Accepted for oral presentation at the American Society of
Neuroradiology, Chicago, USA, 2015. [Abstract]. AJNR.
2. de Havenon A, Stoddard G, Wang H, Chung L, Majersik JJ (May 2015). Increased blood pressure
variable is associated with worse outcome in acute ischemic stroke patients with penumbra.
Accepted for oral presentation at the European Stroke Conference, Vienna, Austria, May 2015.
[Abstract]. Cerebrovascular Diseases.
3. Krug A, Ramirez L, Nhoung H, Perese J, Gasparian G, Kazaryan S, Kelly C, Breen J, Majersik JJ,
Sanossian N (02/12/2015). A Survey of Certified Stroke Center Medical Directors in the United States.
Poster Board Number: P283. Accepted as a poster to the International Stroke Conference, February
11-13, 2015, Nashville, TN, USA [Abstract]. Stroke.
4. Nelson R, Lesko A, Majersik J, Okon N, Bhatt A, Baraban E (2/12/2015). Budget Impact Analysis of
Telestroke in the Pacific Northwest, Abstract, # 3732. Accepted for poster presentation at the
International Stroke Conference February 11 - 13, 2015, Nashville, TN, USA [Abstract]. Stroke.
5. Okon N, Nelson R, Majersik J, Lesko A, Bhatt A, Baraban E (2/11/2015). Telestroke Network Cost-
Effectiveness in the Pacific Northwest: Geography and Facility Size Support a Cost-Sharing Model
Between Hub and Spoke, Abstract #3176. Accepted as a moderated poster presentation to the
International Stroke Conference, February 11 - 13, 2015, Nashville, TN, USA. [Abstract]. Stroke.
6. Baraban E, Nelson R, Lesko A, Majersik J, Bhatt A, Okon (2/11/2015). The Cost-Effectiveness of
Telestroke Varies by Implementation Cost and Stroke Severity: Real World Data From a Pacific
Northwest Network, Abstract # 3665. ccepted for poster presentation at the International Stroke
Conference, February 11 - 13, 2015, Nashville, TN, USA [Abstract]. Stroke.
7. Majersik JJ, Cannon-Albright L (2012). Large Pedigrees at High Risk of Early Stroke Death [Abstract].
8. Majersik JJ, Jex RF, Skalabrin EJ, Taillac PP (May 2012). Development and Initial Results of an Inclusive
State-Wide Approach to Stroke Care [Abstract]. Quality Care and Outcomes Research in
Cardiovascular Disease and Stroke 2012 Scientific Sessions, Atlanta, GA.
S h l d AM M l k S M j ik JJ W ll BB ( / / ) A D b b S d Cl l
Letter
Abstract
9. Southerland AM, Malik S, Majersik JJ, Worrall BB (2/1/2011). Age Distribution by Sex and Clinical
Characteristic in Cervical Artery Dissection. Presented in poster form at the American Academy of
Neurology annual meeting, Honolulu, HI, USA [Abstract].
0. Majersik JJ, Cannon-Albright LA (2010). Evidence for a Heritable Contribution to Death from Ischemic
Stroke. American Academy of Neurology, Toronto, Canada. [Abstract].
1. Nelson RE, Saltzman G, Skalabrin EJ, Majersik JJ (2010). Cost-Effectiveness of Telestroke for Ischemic
Stroke: A Literature-Based Decision-Analytic Model. International Stroke Conference, San Antonio,
TX, USA [Abstract].
2. Cantu CB, Majersik JJ, Sanchez BS, Morgenstern LB (2009). Physician Perception of Acute Stroke
Care in a Mexican Community, American Academy of Neurology, Seattle, WA, USA. [Abstract].
1. de Havenon A, Ney J, Callaghan B, Delic A, Hohmann S, Shippey E, Yaghi S, Anadani M, Esper G,
Majersik J (2020). A Rapid Decrease in Stroke, Acute Coronary Syndrome, and Corresponding
Interventions at 65 United States Hospitals Following Emergence of COVID-19. United States.
(http://www.ncbi.nlm.nih.gov/pubmed/32511563)
2. Majersik JJ, Meurer WJ (2007). The 2007 International Stroke Conference San Francisco, California
February 7-9, 2007. J Neuroophthalmol (27(2), pp. 147-9). United States.
(http://www.ncbi.nlm.nih.gov/pubmed/17549004)
3. Zahuranec DB, Majersik JJ (2006). The 2006 International Stroke Conference Orlando, Florida,
February 15-18, 2006. J Neuroophthalmol (26(2), pp. 156-7). United States.
(http://www.ncbi.nlm.nih.gov/pubmed/16845320)